Akkeri is a consulting group specializing in nonclinical drug development. We provide experienced strategic advice and operational support on drug development programs to include program design, regulatory guidance, scientific & regulatory writing (IND, NDA, CTA, MAA, IB, pre-IND), due diligence, nonclinical study planning, management & monitoring, and project team participation. We have experience across modalities such as small molecules, biologics, cell & gene therapy, and vaccines for a range of therapeutic areas and routes of administration. Our consultants bring a wealth of industry experience from biotech, large pharma, CROs, and FDA. We value a strong working relationship with clients and look forward to an opportunity to partner with your team!
Company Details
- Employees
- 11
- Founded
- -
- Address
- Rare Disease
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://akkeri.com
- Keywords
- Nonclinical Drug Development, Consulting, Nonclinical Consulting, Toxicology, Medical Writing, Nonclinical Study Monitoring, Nonclinical Safety Strategies, Good Laboratory Practices, Gene Therapy, Nonclinical, Regulatory Strategies, FDA Meetings, IND/NDA/BLA, Reproductive Toxicology, Risk Assessment, Preclinical Abuse Liability, Cell Therapy, Ophthalmology, Vaccines, Pharmacokinetics/Toxicokinetic, Permissible Daily Exposure Calculation.
Akkeri, Inc. Questions
Akkeri, Inc.'s website is http://akkeri.com
Akkeri, Inc.'s LinkedIn profile is https://www.linkedin.com/company/akkeri-inc
Akkeri, Inc. has
11 employees.
View email and phone details for 11
employees at Akkeri, Inc..
Akkeri, Inc.'s industry is
Biotechnology Research
Akkeri, Inc.'s categories are Biotechnology Research
Akkeri, Inc.'s founding year is 2023
